Kovack Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Kovack Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 14, 2021	SELL	$86.4 - $121.75 $343,353 - $483,834	-3,974 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$95.43 - $116.09 $4,389 - $5,340	-46 Reduced 1.14%	3,974 $451,000
Q1 2020 Apr 30, 2020	SELL	$47.37 - $90.04 $5,210 - $9,904	-110 Reduced 2.66%	4,020 $259,000
Q4 2019 Jan 29, 2020	BUY	$53.13 - $71.19 $20,826 - $27,906	392 Added 10.49%	4,130 $246,000
Q3 2019 Oct 31, 2019	BUY	$57.11 - $73.3 $5,825 - $7,476	102 Added 2.81%	3,738 $220,000
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $197,834 - $260,701	3,636 New	3,636 $235,000

361

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.